ArticleScientific reports2026

CD80 (B7-1) as a potential therapeutic target in Epstein-Barr virus‑associated B cell diseases.

Rin Yoshizato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.